E2F1 and neuroblastoma: Also, compared with neuroblastoma patients with higher expression levels of E2F1, neuroblastoma patients with lower expression levels of E2F1 had significantly prolonged overall survival in GSE16476 and E-MTAB-1781 datasets (Fig. 3b).